Nurix Licenses a Drug Discovery Program to Sanofi Targeting a Novel Transcription Factor for Autoimmune Diseases

The undisclosed target is a central regulator of inflammation that is distinct from the previously disclosed STAT6 program

Nurix DEL-AI drug discovery engine generated a drug discovery program to this previously undruggable target

Read more at globenewswire.com